UMB Bank’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

UMB Bank’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	–	–	1766
2023 Q1	$0	Hold	5	–	–	﹤0.01%	1813
2022 Q4	$0	Hold	5	–	–	﹤0.01%	1871
2022 Q3	$0	Hold	5	–	–	﹤0.01%	2024
2022 Q2	$0	Hold	5	–	–	﹤0.01%	2075
2022 Q1	$0	Hold	5	–	–	﹤0.01%	2107
2021 Q4	$0	Buy	+5	New	+$15	﹤0.01%	2014

Other funds holding STAB

TAM

Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

UMB Bank's STAB Position: Q2 2023 in Review

UMB Bank sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q2 2023, closing a stake of 5 shares.

UMB Bank first reported a position in STAB in Q4 2021 and held it in 6 quarters. The position peaked at $0 in Q1 2023. 1 fund tracked by Wall St. Rank holds STAB as of Q2 2023.

UMB Bank reported no remaining Statera Biopharma, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
UMB Bank sold 5 Statera Biopharma, Inc. Common Stock shares in Q2 2023.
UMB Bank first reported a position in Statera Biopharma, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
UMB Bank's Statera Biopharma, Inc. Common Stock position peaked at $0 in Q1 2023.
1 fund tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2023.

Based on UMB Bank's 13F filing for Q2 2023, filed 25 Jul 2023.